Key View

• We hold a positive outlook for the growth of the fintech market in Brazil following a slew of efforts by the financial regulators to boost competition. These include the launch of a unified, instant payments system and a fintech sandbox, as well as the introduction of new regulatory frameworks.
• Brazil boasts positive demographic

Key View

• We have revised down our Brazil 2021/22 sugar production forecast to decline by 6.0% y-o-y, after the bumper output to be recorded in the ongoing 2020/21.
• We expect less cane to be diverted to sugar production in 2021/22 compared with the previous season. This comes as we forecast crude oil prices to partially recover from a sharp

Key View

• We maintain our forecast for Brazil’s soybean production to decline by 0.8% y-o-y in 2020/21, compared with the growth in output currently expected by the USDA.
• La Niña conditions, which have re-emerged in August 2020 and will most likely continue into Q121, have already led to unseasonal dry weather, significantly delaying plantings

Key View

• Brazil’s Ministry of Health has accelerated more than 60 patent examinations related to Covid-19.
• Faster patent application examinations appealing to drugmakers.
• Brazil’s macroeconomic environment will continue to face challenges over the long-term.

Brazil’s Ministry of Health has accelerated more than 60 patent examinations

Key View

• Brazil is expected to expand natural gas infrastructure to comply with new climate commitments and maintain a positive growth rate in oil production from pre-salt area.
• The drop in crude oil and natural gas prices darken our outlook for the offshore pipeline infrastructure expansion projects over the short term. However, we remain

Key View: Macroeconomic weakness will restrict the uptake of pharmaceuticals in Brazil. Access to the latest healthcare innovations to remain limited. Brazil’s economic growth dampened by Covid-19.

Macroeconomic weakness will restrict the uptake of pharmaceuticals in Brazil. We at Fitch Solutions now expect combined sales of prescription drugs

Key View

• Brazil's new renewables auctions as well as the resumption of transmission auctions indicate growth potential in the country's power sector, despite a weakened near-term outlook as a result of the Covid-19 pandemic.
• Our forecasts are underlined by plans to continue the transmission auctions through to 2022, which will support growth

The Latest: On August 18 2020, the Brazilian health regulatory approved human clinical trials for a Covid-19 vaccine candidate, Ad26.COV2.S, developed by Johnson & Johnson's (J&J)'s pharmaceutical subsidiary, Janssen. The randomised, controlled, double-blind, Phase III trial will involve 6,000 volunteers from Brazil and a total of 60,000

Key View

• Beyond Meat is entering the increasingly competitive market of alternative protein in Brazil. Where it was once a disruptor, Beyond Meat will be now be chasing market share in Brazil, with a number of domestic and international meat and food processing companies having already launched their own alternative protein products.
• Beyond

Despite being home to one of the world’s largest stock exchanges, Brazil has struggled to record a strong flow of IPO activity over recent years. We believe that deal levels on the São Paulo Stock Exchange (or commonly known as the Bovespa bourse) will also remain low in the near term, with the country expected to see a forecast sharp contraction